» Authors » Jung-Han Yoon

Jung-Han Yoon

Explore the profile of Jung-Han Yoon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 1066
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Baek J, Choi B, Rha S, Choi C, Park C, Seo H, et al.
Am J Cardiol . 2019 Sep; 124(10):1493-1500. PMID: 31547996
The study compared the 2-year outcomes of patients diagnosed with acute myocardial infarction (AMI) triggered by coronary artery atherosclerosis and AMI caused by coronary artery spasm. A total of 36,797...
3.
Kim C, Park K, Kang J, Park B, Cha K, Rhew J, et al.
Circ J . 2019 Jun; 83(7):1489-1497. PMID: 31155604
Background: There are limited data on the long-term outcome of platinum chromium-based everolimus-eluting stents (PtCr-EES) vs. cobalt chromium-based zotarolimus-eluting stents (CoCr-ZES). Methods and results: A total of 3,755 patients undergoing...
4.
Jung Y, Lee S, Lee J, Noh W, Nam S, Park B, et al.
J Breast Cancer . 2018 Jul; 21(2):182-189. PMID: 29963114
Purpose: There are few reports from Asian countries about the long-term results of aromatase inhibitor adjuvant treatment for breast cancer. This observational study aimed to evaluate the long-term effects of...
5.
Kim S, Kim S, Shin I, Park M, Yoon J, Yoon J, et al.
Gen Hosp Psychiatry . 2017 Oct; 50:33-37. PMID: 28987920
Objective: Although breast cancer patients' depression changes over time, most longitudinal studies have assessed the influence of only baseline depression on quality of life (QoL). Therefore, this study investigated the...
6.
Park K, Rhee T, Kang H, Koo B, Gwon H, Yoon J, et al.
Circ J . 2017 Oct; 82(6):1566-1574. PMID: 28966335
Background: Everolimus-eluting stents (EES) have equivalent short-term angiographic and clinical outcomes to sirolimus-eluting stents (SES), but EES may be superior to SES with regard to long-term clinical safety. We report...
7.
Lee J, Kim S, Choi D, Tahk S, Yoon J, Choi S, et al.
Drug Des Devel Ther . 2017 Aug; 11:2277-2285. PMID: 28814835
Purpose: This study was designed to compare the efficacy and tolerability of the generic formulation (Atorva) and the reference formulation (Lipitor) of atorvastatin, both at a dosage of 20 mg...
8.
Sohn I, Kim C, Ahn T, Youn H, Jeon H, Ihm S, et al.
Clin Ther . 2017 Jul; 39(8):1628-1638. PMID: 28734660
Purpose: Intensive blood pressure (BP) lowering is important for the treatment of hypertension; however, it has been a challenge to achieve target BP in many patients. The purpose of this...
9.
Ahn J, Park D, Shin E, Koo B, Nam C, Doh J, et al.
Circulation . 2017 Mar; 135(23):2241-2251. PMID: 28356440
Background: We evaluated the prognosis of deferred and revascularized coronary stenoses after fractional flow reserve (FFR) measurement to assess its revascularization threshold in clinical practice. Methods: The IRIS-FFR registry (Interventional...
10.
Joo H, Cho S, Hong S, Hur S, Bae J, Choi D, et al.
Lipids Health Dis . 2016 Nov; 15(1):197. PMID: 27863493
Background: It is still unclear whether low high-density lipoprotein cholesterol (HDL-C) affects cardiovascular outcomes after acute myocardial infarction (AMI), especially in patients with diabetes mellitus. Methods: A total of 984...